PCAS: 2020 annual results
Results The PCAS Group has generated consolidated net sales of €194.1 million in fiscal year 2020, a decrease of 3.4% (-2.7% at constant exchange rates) compared to fiscal year 2019. The EBITDA amounted to €10.7 million, compared to €16.3 million in 2019 (i.e. a margin of 5.5% versus 8.1% in 2019) and was primarily impacted negatively by the delay in commissioning the new production unit at the Villeneuve-la-Garenne site, the significant drop in demand for Lubricants linked to the coronav...
Emmanuel Huynh Louis Victor Delouvrier Pierre Luzeau Eric Moissenot Euronext Paris Pharmaceutical Synthesis Net Current Account Annual General Meeting
Source: globenewswire.com